SCHEMBL24428824

SCHEMBL24428824

CCOC(=O)C(CO)CCNC(=O)OC(C)(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
GAA P10253 1/20 0.53
TDP1 Q9NUW8 1/20 0.47
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTT P42858 1/20 0.41
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA9 Q16790 2/20 0.40
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
EPHX1 P07099 1/20 0.38
CTSK P43235 4/20 0.37
CTSS P25774 2/20 0.36
MALT1 Q9UDY8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18175792 1.00 MEN1 (0.53) MEN1KMT2AGAATDP1CYP1A2
SCHEMBL14932468 1.00 MEN1 (0.53) MEN1KMT2AGAATDP1CYP1A2
SCHEMBL20578500 0.93 MEN1 (0.63) MEN1KMT2AGAATDP1CYP1A2
SCHEMBL26790537 0.89 MEN1 (0.54) MEN1KMT2AGAATDP1CYP1A2
SCHEMBL7442826 0.84 MEN1 (0.44) MEN1KMT2AGAATDP1CYP1A2
SCHEMBL28079376 0.83 MEN1 (0.71) MEN1KMT2AGAATDP1HTT
SCHEMBL18760388 0.83 MEN1 (0.53) MEN1KMT2AGAATDP1CYP1A2
SCHEMBL8012876 0.81 MEN1 (0.51) MEN1KMT2AGAATDP1CYP1A2
SCHEMBL8017155 0.81 MEN1 (0.51) MEN1KMT2AGAATDP1CYP1A2
SCHEMBL24428751 0.79 SYK (0.55) MEN1KMT2AGAAHTTCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3256446-B1 (2S,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-4-(ETHOXYOXALYLAMINO)-2-HYDROXYMETHYL-2-METHYLPENTANOIC ACID AS NEPRILYSIN INHIBITOR THERAVANCE BIOPHARMA R&D IP LLC (US) 2022-05-18 EP disclosed